Drug Profile
Research programme: pain therapeutics - Dompe
Alternative Names: BKB1r antagonists - Dompe; c5ar antagonists - DompeLatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Dompe Farmaceutici
- Class Analgesics
- Mechanism of Action Bradykinin B1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neuropathic pain; Pain
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Neuropathic-pain in Italy
- 28 Jul 2018 No recent reports of development identified for research development in Pain in Italy
- 19 Jul 2016 Early research is ongoing in Italy